生物制品板块12月1日涨0.23%，禾元生物领涨，主力资金净流出2.73亿元

Core Viewpoint - The biopharmaceutical sector experienced a slight increase of 0.23% on December 1, with He Yuan Bio leading the gains. The Shanghai Composite Index rose by 0.65%, while the Shenzhen Component Index increased by 1.25% [1]. Group 1: Market Performance - The biopharmaceutical sector's performance on December 1 showed a mixed trend, with notable gainers including He Yuan Bio, which closed at 81.60 with a rise of 3.29%, and Kanghua Bio, which closed at 84.21 with a rise of 2.93% [1]. - The overall trading volume in the biopharmaceutical sector was significant, with He Yuan Bio achieving a transaction amount of 336 million yuan and Kanghua Bio reaching 351 million yuan [1]. Group 2: Individual Stock Performance - The table of individual stock performance indicates that several companies in the biopharmaceutical sector saw positive price movements, with Te Bao Bio and Wu Xi Jing Hai also recording increases of 2.81% and 2.51%, respectively [1]. - Conversely, some companies faced declines, such as Rong Chang Bio, which fell by 4.47%, and Bai Pu Sai Si, which decreased by 3.65% [2]. Group 3: Capital Flow - The biopharmaceutical sector experienced a net outflow of 273 million yuan from institutional investors, while retail investors contributed a net inflow of 178 million yuan [2]. - The capital flow data highlights that He Yuan Bio attracted a net inflow of 51.47 million yuan from institutional investors, despite a net outflow from retail investors [3].